Alan J. Russell, Chief Scientific Officer at Edgewise Therapeutics, Inc. (EWTX), sold 100,000 shares at $21.12 ($2.1M) on 2025-11-12, disclosed to the SEC on 2025-11-13.
Open-market sale of $2.1M EWTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EWTX | SELL | 2025-08-28 | $1.5M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $26K | — | Filing → |
| EWTX | SELL | 2025-05-07 | $26K | — | Filing → |